Drug producer Terapia Ranbaxy grew its sales by 21 percent in the first half of the year in Romania, to USD 48 million, according to the company's most recent financial report. The company was helped by the restructuring process and by rationalization, which counterbalanced the negative market conditions, according to the company. The increase in sales was higher in the second quarter, when Ranbaxy sold USD 24 million of products in Romania, 27 percent more that in the same period of last year. Worldwide, the group's performances were even better, with an increase of 42 percent, to USD 682 million in the first half of the year, mainly due to the US market.

Related articles by Zemanta

• Daiichi Sankyo and Ranbaxy to Integrate New Drug Research and Development System (worldpharmanews.com)
• Ranbaxy first quarter net sales surges 65 per cent (newstatesman.com)
• Ranbaxy Profit Slumps 53% (online.wsj.com)